G A. Colloca-Giuseppe
Via G. Borea N. 56, Sanremo
Imperia, 18038, Italy
Imperia, 18038, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Leukocyte kinetics during the first cycle of chemotherapy predicts the outcome of patients with metastatic colorectal cancer and previous resection of the primary tumor.
Journal: International journal of colorectal disease
Published: December 09, 2020
Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracil.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 24, 2020
TAS-102 plus bevacizumab in metastatic colorectal cancer.
Journal: The Lancet. Oncology
Published: March 24, 2020
Reduction of derived neutrophil-to-lymphocyte ratio after four weeks predicts the outcome of patients receiving second-line chemotherapy for metastatic colorectal cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: March 21, 2020
Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 17, 2019
Tumor growth kinetics by CA 19-9 in patients with unresectable pancreatic cancer receiving chemotherapy: A retrospective analysis.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: October 26, 2019
Retrospective analysis by site of primary tumor of patients with unresectable locally-advanced or metastatic pancreatic adenocarcinoma receiving chemotherapy.
Journal: Clinical & experimental metastasis
Published: June 15, 2019
Analysis of response-related endpoints in trials of first-line medical treatment of metastatic colorectal cancer.
Journal: International journal of clinical oncology
Published: May 20, 2019
Neutrophil-related Variables Have Different Prognostic Effect Based on Primary Tumor Location in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy.
Journal: Clinical colorectal cancer
Published: December 31, 2018
Carcinoembryonic antigen reduction after medical treatment in patients with metastatic colorectal cancer: a systematic review and meta-analysis.
Journal: International journal of colorectal disease
Published: December 27, 2018
Second-generation inflammation-related scores are more effective than systemic inflammation ratios in predicting prognosis of patients with unresectable or metastatic pancreatic cancer receiving cytotoxic chemotherapy.
Journal: Medical oncology (Northwood, London, England)
Published: July 26, 2018
Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis.
Journal: Medical oncology (Northwood, London, England)
Published: August 30, 2017
Last Updated: 09/26/2026